Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

Consolidated Statements of Changes in Equity

v3.21.1
Consolidated Statements of Changes in Equity - USD ($)
$ in Thousands
Ordinary shares
Additional paid-in capital
Accumulated other comprehensive Income
Accumulated deficit
Total
Balance at Dec. 31, 2017 $ 2,123 $ 90,499 $ 1,127 $ (90,765) $ 2,984
Balance (in Shares) at Dec. 31, 2017 33,295,618        
Liability reclassified to equity [1] 2,030 2,030
Cumulative effect of initial adoption of ASC 606 as of January 1, 2018 (350) (350)
Issuance of share capital and warrants, net of issuance expenses $ 482 3,905 4,387
Issuance of share capital and warrants, net of issuance expenses (in Shares) 6,667,672        
Issuance of share capital $ 30 252 282
Issuance of share capital (in Shares) 437,000        
Share-based payments 253 253
Net loss (6,571) (6,571)
Balance at Dec. 31, 2018 $ 2,635 96,939 1,127 (97,686) 3,015
Balance (in Shares) at Dec. 31, 2018 40,399,290        
Issuance of share capital and warrants, net of issuance expenses $ 5,518 6,149 11,667
Issuance of share capital and warrants, net of issuance expenses (in Shares) 79,256,703        
Issuance of share capital $ 72 43 115
Issuance of share capital (in Shares) 996,690        
Share-based payments 270 270
Net loss (12,625) (12,625)
Balance at Dec. 31, 2019 $ 8,225 103,401 1,127 (110,311) 2,442
Balance (in Shares) at Dec. 31, 2019 120,652,683        
Deemed dividends related to the warrants exercise (Note 10b(6)) 715 (715)
Issuance of share capital and warrants, net of issuance expenses $ 24,711 (7,028) 17,683
Issuance of share capital and warrants, net of issuance expenses (in Shares) 341,766,780        
Issuance of share capital $ 100 (25) 75
Issuance of share capital (in Shares) 1,350,000        
Share-based payments 317 317
Net loss (14,443) (14,443)
Balance at Dec. 31, 2020 $ 33,036 $ 97,380 $ 1,127 $ (125,469) $ 6,074
Balance (in Shares) at Dec. 31, 2020 463,769,463        
[1] See note 2c.